GoodRx Holdings Profit Margin

GoodRx Holdings (GDRX) currently reports a profit margin of 9.86% as of June 2026. That compares with 6.77% in the prior-year period — up 45.6% year over year. That is below the Technology sector average of 37.3%. Use the charts on this page to explore GoodRx Holdings's profit margin history and peer comparisons.

GoodRx Holdings's profit margin increased from 6.77% to 9.86% — a 45.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GoodRx Holdings's profit margin of 9.86% is lower than the Technology sector average of 37.3%. That is roughly 73.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but GoodRx Holdings's current 9.86% should be judged against Technology norms (sector average: 37.3%) and against GDRX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 9.86%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 37.3%. From there, open related valuation or income-statement pages for GoodRx Holdings, and consider following GDRX for alerts when major investors trade the stock.